Advertisement
Nearly one-third of cancer deaths among Americans aged 35 or older are caused by smoking

Smoking Still Responsible for Many U.S. Cancer Deaths

0
Linked to close to one-third of fatal cancers in patients 35 and older
For breast cancer care

Bundled-Payment Program Deemed Better for Breast CA Care

0
Better adherence to quality indicators, outcome, and cost control over time in Taiwanese study
For men with low-risk prostate cancer

Higher Grade Disease at Prostatectomy With Surveillance

0
No difference in other adverse pathological outcomes versus men undergoing immediate surgery
Compared with laparoscopic partial nephrectomy

Superior Morbidity Profile for Robotic Partial Nephrectomy

0
Lower likelihood of conversion to laparoscopic/open surgery, complications, positive margins
Healthy living can lower the odds for colorectal cancer for men who are at high genetic risk for the disease

Men With Genetic Risk of CRC May Lower Risk Via Healthy Lifestyle

0
Adopting healthy lifestyle can cut 25-year risk for the disease from 29 to 13 percent
More than 90 percent of men in Sweden who have very low-risk prostate cancer choose close monitoring rather than immediate treatment -- and more American men should use that option

Surveillance Rates on Rise in Low-Risk Prostate Cancer

0
In Sweden, 90 percent with very low-risk disease choose this option instead of immediate treatment
Financial toxicity is a clinically relevant outcome for patients receiving treatment for advanced cancer

Financial Toxicity Is a Relevant Cancer Outcome Measure

0
Health-related quality of life correlated with financial toxicity in cancer patients
Fear of cancer recurrence seems to be a primary reason why breast cancer patients choose to have their cancer-free breast removed at the same time as their affected breast

ACS: Contralateral Mastectomy Rates Up in Breast CA Patients

0
Reasons include thinking it is the best treatment for breast cancer and fear of recurrence
Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

0
Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery
For patients with advanced retinoblastoma

Topotecan-Based Therapy Beneficial for Retinoblastoma

0
Findings show globe salvage with vision for topotecan plus vincristine, carboplatin, focal therapy